O Tsybakova

Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

Pedro Cahn, Richard Kaplan, Paul E. Sax et al. · The Lancet HIV · 2017 · 35 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Once-daily S/GSK1349572 combination therapy in antiretroviral-naïve adults: rapid and potent 24-week antiviral responses in SPRING-1 (ING112276)

Jürgen K. Rockstroh, Franco Felizarta, Franco Maggiolo et al. · Journal of the International AIDS Society · 2010 · 14 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Week 48 Resistance Analyses of the Once-Daily, Single-Tablet Regimen Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) in Adults Living with HIV-1 from the Phase III Randomized AMBER and EMERALD Trials

Erkki Lathouwers, Eric Wong, Kimberley Brown et al. · AIDS Research and Human Retroviruses · 2019 · 14 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17